2024年11月4日,辉大基因宣布其针对新生血管性年龄相关性黄斑变性(nAMD)的HG202新药临床试验申请(IND)已获得美国FDA批准。 管理团队 陆英明,CEO; 施霖宇,CSO; TJ Cradick,CTO; 张昕(2024年9月9日任命),CMO(首席医学官&首席运营官); 王中元,CFO; 公司简介 辉大生物,全称辉大(上海)生物科技有限公司,是一家于...
Few important dates a candidate should keep in mind- Opening date of Online Application: 20.03.2024 Closing date of Online Application: 19.04.2024 For More Information::Click Herefor the Official Notification of NLC vacancy. Posts of NLC vacancy: Recruitment process will be done for filling up t...
Candidates who are willing to apply for this job, they need to be satisfy the age limits (upper age and lower age) – For this job a candidates age should not less than 20 years and should not exceed 30 years as on 01.01.2024. Educational Qualification for WBP vacancy: Another criteria ...